RxDoctor Payments Data

Scott Bartley

Psychiatry · Dallas, TXNPI 1255342143

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,801 of the $2,158 with a category attached, or 83.5%. Avanir Pharmaceuticals, Inc. accounts for 94.5% of it on its own, with 1 other manufacturer making up the rest.

$2,158in general payments, 2019–2025

Across 16 payments — averaging $134.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanir Pharmaceuticals, Inc.$2K
  • Alkermes, Inc.$118
$42,729,163in research payments, 2019–2025

Across 3,176 payments — averaging $13,454 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sumitomo Pharma America, Inc.$11.4M
  • Teva Pharmaceuticals USA, Inc.$7.1M
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$6.1M
  • Sunovion Pharmaceuticals Inc.$3.5M
  • E.r. Squibb & Sons, L.L.C.$3.3M
  • AbbVie$3M
  • plus $8.4M from 25 others

What the payments were for

  • Travel & lodging$1,80183%
  • Food & beverage$35717%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Avanir Pharmaceuticals, Inc.15$2,040
Alkermes, Inc.1$118

How this compares

$2,158 in reported general payments places this provider in the 80th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Other psychiatry in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →